ADC Therapeutics (ADCT) Convertible Debt (2021)
Historic Convertible Debt for ADC Therapeutics (ADCT) over the last 1 years, with Q4 2021 value amounting to $113.8 million.
- ADC Therapeutics' Convertible Debt changed N/A to $113.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $113.8 million, marking a year-over-year change of. This contributed to the annual value of $113.8 million for FY2021, which is N/A changed from last year.
- Per ADC Therapeutics' latest filing, its Convertible Debt stood at $113.8 million for Q4 2021.
- In the past 5 years, ADC Therapeutics' Convertible Debt registered a high of $113.8 million during Q4 2021, and its lowest value of $113.8 million during Q4 2021.